Trending Articles

  1. Sanofi completes acquisition of Blueprint Medicines Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company...
  2. Evestia Clinical to merge with Atlantic Research Group The merger delivers on Evestia Clinical’s strategy of targeted growth through the expansion of services, enhanced technology and broadened geographical reach
  3. Amphista Therapeutics reaches research milestone and triggers a milestone payment from Merck Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications
  4. Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
  5. Strategic investment by Bain Capital, Kohlberg and Mubadala fuels PCI Pharma Services’ expansion This financial injection is expected to cement PCI’s position in the CDMO arena

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Finance Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company...

Sanofi completes acquisition of Blueprint Medicines

Read more
Finance The merger delivers on Evestia Clinical’s strategy of targeted growth through the expansion of services, enhanced technology and broadened geographical reach

Evestia Clinical to merge with Atlantic Research Group

Read more
Research & Development Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications

Amphista Therapeutics reaches research milestone and triggers a milestone payment from Merck

Read more
Manufacturing Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Read more
Research & Development This financial injection is expected to cement PCI’s position in the CDMO arena

Strategic investment by Bain Capital, Kohlberg and Mubadala fuels PCI Pharma Services’ expansion

Read more
Finance The ex-Novo Nordisk researcher-founded biotech will use the money to expand its obesity clinical pipeline

Pila Pharma bags nearly £1.5m to aid obesity drug development

Read more
Research & Development Ofichem will now be able to offer its clients a range of early-stage development services, from analytical method development to excipient characterisation

Ofichem Group to acquire drug formulation development specialist, Avivia

Read more
Manufacturing Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon,...

Almac completes a multi-million-pound investment enhancing cold chain capabilities in Craigavon

Read more
Research & Development The company will now progress APN-sEV into clinical trials, while scaling up its GMP manufacture to a large scale

Ciloa bags €6.5m in funding to progress obesity therapy's clinical development

Read more
Finance Acquisition is another milestone of Siemens’ ONE Tech Company program expanding Siemens’ offerings into the life sciences industry with stronger customer focus, faster...

Siemens completes acquisition of Dotmatics

Read more
Finance Functional data has been generated, demonstrating enhanced tumour control for both primary T-cell and Macrophage programmes, representing key milestones

Laverock Therapeutics expands seed funding and announces key milestone progress

Read more
Finance STALICLA SA has announced the successful closing of a CHF 2m financing led by Addex Therapeutics

Stalicla secures financing to advance precision medicine neurodevelopmental disorder programmes

Read more
Finance The hereditary angiodema-targeting prescription medication is being sold to pay off term debt from Pharmakon

BioCryst to sell Orladeyo to Neopharmaed Gentili for $264m

Read more
Finance The company will now be able to offer its client base a range of sanitary pumps for gentle, contactless fluid handling

PSG acquires sanitary pump manufacturer, ipp Pump Products

Read more
Ingredients This acquisition will bolster IMCD's portfolio of specialty pharmaceutical ingredients

IMCD bolsters API portfolio with Trichem Healthcare acquisition

Read more
Research & Development Superlab Suisse has announced the opening of its fourth Swiss laboratory facility at Campus Biotech in Geneva, which will be ready for move-in by January 2026

Superlab Suisse to open new facility at Campus Biotech in Geneva in January 2026

Read more